Page last updated: 2024-08-24

3-aminoisobutyric acid and Hypertension

3-aminoisobutyric acid has been researched along with Hypertension in 2 studies

*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ahmad, H; Chen, L; Chen, S; Chen, X; Du, J; Gao, D; Jin, Y; OuYang, Y; Tian, Z; Yang, Z; Zhao, X; Zheng, X; Zhou, L1
Hou, XW; Li, X; Wang, YB; Yin, B1

Other Studies

2 other study(ies) available for 3-aminoisobutyric acid and Hypertension

ArticleYear
β-Aminoisobutyric acid supplementation attenuated salt-sensitive hypertension in Dahl salt-sensitive rats through prevention of insufficient fumarase.
    Amino acids, 2022, Volume: 54, Issue:2

    Topics: Aminoisobutyric Acids; Animals; Blood Pressure; Dietary Supplements; Fumarate Hydratase; Hypertension; Rats; Rats, Inbred Dahl

2022
β‑aminoisobutyric acid ameliorates hypertensive vascular remodeling via activating the AMPK/SIRT1 pathway in VSMCs.
    Bioengineered, 2022, Volume: 13, Issue:6

    Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Hypertension; Kelch-Like ECH-Associated Protein 1; Muscle, Smooth, Vascular; NF-E2-Related Factor 2; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sirtuin 1; Vascular Remodeling

2022